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Abstract
Background: Limited evidence suggests that exposure to maternal smoking in utero or
early life might be associated with chronic obstructive pulmonary disease (COPD), but
whether this is independent of later own smoking remains unclear. Our objective was to
examine the independent and combined association of maternal and own smoking with
adult lung function and COPD.
Methods: We used UK Biobank to examine associations of maternal smoking around
delivery, and pack-years of own smoking, with lung function (n¼ 502626) and hospitali-
zation/death from COPD (n¼ 433 863). We calculated the additive interaction between
maternal and own smoking on the outcomes of interest, and estimated the association
with maternal smoking within categories of own smoking.
Results: There was no strong evidence that maternal smoking influenced adult lung
health among never smokers. Exposure to both maternal and own smoking was associ-
ated with lower Forced expiratory volume (FEV1)/ forced vital capacity (FVC) and greater
risk of hospitalization/death from COPD than expected from their independent
associations. For FEV1/FVC, the mean difference according to maternal smoking was
–0.02 (–0.06, 0.02), –0.01 (–0.05, 0.03), –0.11 (–0.16, –0.05) and –0.11 (–0.19, –0.04) among
women who smoked 10, 11–20, 21–30 and >30 pack-years, respectively. The associa-
tion between maternal smoking and COPD also varied by pack-years of own smoking,
with a hazard ratio of 2.25 (1.30, 3.89) for 10 years, 1.23 (0.80, 1.89) for 11–20 years, 1.30
(0.85, 2.01) for 21–30 years and 1.14 (0.91, 1.43) for >30 years.
VC The Author(s) 2018. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
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Conclusions: Our findings indicate an excess reduction in FEV1/FVC and risk of COPD
due to maternal smoking that is heterogeneous across levels of own smoking.
Key words: chronic obstructive pulmonary disease, spirometry, maternal, smoking, UK Biobank
Introduction
The main modifiable risk factor for chronic obstructive
pulmonary disease (COPD) is own smoking. However, a
sizable proportion (25–45%) of COPD occurs among
never smokers.1 It is therefore important to identify further
contributing causes of COPD. Based on the observation
that environmental exposures during pregnancy and early
childhood influence lung function in early life,2–4 which
shows a strong degree of tracking throughout the life
course,5 it is plausible that early-life environment affects
COPD risk.
Maternal smoking during pregnancy is associated with
increased wheezing illness and diminished lung function
during childhood.6 It remains uncertain whether maternal
smoking might also have a continued impact on adult lung
health. A few previous studies stemming from two inde-
pendent cohorts looked at maternal smoking and adult
lung function.7–9 These studies indicate an association be-
tween maternal smoking and adult lung function that was
seemingly independent of own smoking after traditional
multivariable adjustment.7–9
Two of the previous studies suggest that the combined
exposure to maternal and own smoking resulted in an ex-
cess reduction in lung function/greater rate of lung-
function decline.7,9 Only one study examined maternal
smoking in relation to COPD, but this study could not ex-
amine independent and combined associations with mater-
nal and own smoking with COPD due to its limited sample
size.7 It therefore remains unclear whether there might be
an interaction between these two exposures on COPD risk,
and what the direct effect of maternal smoking on COPD
risk might be in the presence of an interaction.
The objective of the current study was to examine the
independent and combined associations of maternal and
own smoking with adult lung function and hospitaliza-
tion/death from COPD in the UK Biobank cohort.
Methods
Study population
We studied participants in UK Biobank, including 503 325
people between 40 and 69 years of age, who were recruited
between 2006 and 2010, from 22 assessment centres across
England, Scotland and Wales.10,11 The participation rate was
5% and all participants gave written informed consent.
Participants were followed through national hospital and
death registers. Information from both registries was avail-
able until 28 February 2015 for England, 16 March 2015 for
Wales and 28 October 2014 for Scotland. Ethical approval
for UK Biobank was obtained from the NHS National
Research Ethics Service (Ref 11/NW/0382). The data avail-
able included 502 629 individuals due to withdrawals. After
excluding 3 individuals registered as deceased before enrol-
ment, 502 626 were eligible for the current study.
Exposure
Participants were asked: Did your mother smoke regularly
around the time when you were born? The answer options
were ‘no’, ‘yes’ and ‘don’t know’. Based on self-reported
information on age at smoking initiation, average number
of cigarettes/cigars/pipes smoked per day, age of smoking
cessation (for former smokers) and age at recruitment (for
current smokers), we calculated the number of pack-years
Key Messages
• Our findings from UK Biobank show that exposure to both maternal and own smoking resulted in a reduction in lung
function and increased risk of chronic obstructive pulmonary disease (COPD) that exceeded what was expected based
on their independent associations.
• The magnitude of the association between maternal smoking and Forced expiratory volume (FEV1)/ forced vital
capacity (FVC) increased with greater number of pack-years of own smoking, whereas the magnitude of the associa-
tion between maternal smoking and hospitalization/death from COPD was greatest among those who had smoked
<10pack-years.
• These results suggest that public-health initiatives supporting the current trend of reduction in smoking may have
benefits for the lung health of two generations.
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of smoking at baseline. Pack-years of own smoking was
categorized as none, up to 10 years, between 11 and
20 years, between 21 and 30 years, and more than 30 years.
The exposure consisted of 10 mutually exclusive categories
of maternal and pack-years of own smoking.
Spirometry measurements
Forced expiratory volume (FEV1) and forced vital capacity
(FVC) were measured at baseline using Vitalograph
Pneumotrac 6800 (Vitalograph, UK). Spirometry was not
conducted if participants had experienced a chest infection in
the last month; had a life-time history of detached retina or
collapsed lung; if they had been through a heart attack, eye
surgery or surgery to chest or abdomen in last 3 months; or if
they were currently pregnant or on tuberculosis medications.
If the reproducibility of the first two measurements was ade-
quate, defined as a 5% difference in FVC and FEV1, a
third measurement was not required. Post-bronchodilator
spirometry was not available, although drug treatment was
not withheld. The spirometry measurements were internally
standardized by age, sex and height before analysis.
COPD
COPD at baseline was defined based on self-report, histori-
cal diagnosis in the national hospital registers and/or a
FEV1/FVC <0.7 according to the Global Initiative for
Chronic Obstructive Lung Disease (GOLD) criteria.12
Incident hospitalization/death from COPD after baseline
was identified from national registers. The registers are
coded according to the International Classification of
Diseases (ICD). ICD codes that were used to define COPD
included ICD-9 codes 490–492, 494 and 496, in addition
to ICD-10 codes J40–44.
Covariates
Additional information obtained by self-report included age,
sex, ethnicity (European vs other), educational qualifications
(college, university or other professional degree, Advance
levels/Advance Subsidiary levels or equivalent, Ordinary lev-
els/General Certificate of Secondary Educations or equiva-
lent, National Vocational Qualifications, Higher National
Diploma, Higher National Certificate or equivalent, other),
average household income (less than £18 000, £18 000–
30 999, £31 000–51 999, £52 000–100 000, >£100 0000
and ‘prefer not to answer/don’t know’) and Townsend area-
level deprivation index. Nurses measured participants’ height
and weight at baseline, which was subsequently used to cal-
culate body mass index (BMI; weight in kilograms/height in
meters2). Asthma at baseline was defined using self-report
and historical diagnosis in the national hospital registers
(ICD9 code 493; ICD10 codes JJ45 and JJ46). A simplified
illustration of the underlying theoretical framework is pro-
vided in Figure 1. Notably, it is not possible to illustrate a
potential interaction between maternal and own smoking on
offspring adult lung health in such a theoretical framework.
Statistical analysis
We imputed 20 datasets with missing covariate informa-
tion using multiple imputation by fully conditional specifi-
cation (chained equations).13 The amount of missing
information on individual covariates ranged from none
(age, sex and asthma at baseline) to 28% (spirometry
measurements). For individuals who responded ‘don’t
know’ to whether their mother smoked (14%), we set the
value to missing and subsequently imputed the value for
maternal smoking. The imputation model included the
covariates described above, birthweight, parental history
Figure 1. Simplified illustration of the underlying theoretical framework. aPotential confounders of the association between the exposure and the me-
diator. Participants’ own socio-economic status and ethnicity were used as a proxies for maternal socio-economic status and ethnicity. bPotential con-
founders of the association between the mediator and outcome. Available measures included age, sex, ethnicity, socio-economic status, BMI and
history of asthma. cConfounders of the association between the exposure and outcome. Participants’ own socio-economic status and ethnicity were
used as proxies for maternal socio-economic status and ethnicity. Available measures for socio-economic status included qualifications, income and
Townsend area-level deprivation index.
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of COPD, country of residence and interaction terms for
maternal and own smoking. We present the results from
the complete-case analysis in the supplement, and the study
population available for this analysis is illustrated in
Supplementary Figure 1, available as Supplementary data
at IJE online.
We examined maternal and pack-years of own smoking
in relation to the standardized spirometry measurements
using linear regression, reporting mean differences (b) and
95% confidence intervals (CIs). We calculated the associa-
tions of the mutually exclusive exposure categories of
maternal and pack-years of own smoking with incident
hospitalization/death from COPD using Cox proportional
hazards regression, reporting hazard ratios (HRs) and
95% CI. We also tested for heterogeneity in the associa-
tions of maternal and own smoking with adult lung health
by sex.
Instead of conventional multivariable adjustment for
potential confounders, we used marginal structural models
(MSMs), since some of the confounders of the association
between own smoking and adult lung health could be
influenced by maternal smoking (such as asthma and
BMI).14–16 The inverse probability weight for maternal
smoking was calculated from a logistic regression model
including the participant’s age, sex, ethnicity, qualifica-
tions, income and Townsend area-level deprivation index.
The inverse probability of pack-years of own smoking was
calculated from a multinomial logistic regression model
adjusting for these same background characteristics, in ad-
dition to maternal smoking, BMI and asthma at base-
line.14–16 We subsequently stabilized these two weights
before using their product as the final analytical weight.
We were interested in an additive interaction between
maternal and own smoking, which was estimated by in-
cluding product terms in the linear regression for the spi-
rometry measurements, whereas the relative excess risk
due to interaction (RERI) was calculated as a measure of
additive interaction for hospitalization/death from
COPD.17 Since we found some evidence of an interaction,
we then estimated the association with maternal smoking
within levels of own smoking, by adding together the coef-
ficients for maternal smoking and the interaction terms for
each group of own smoking, and calculating the CIs using
the delta method.16
As a secondary analysis, we estimated the associations
of maternal and own smoking with COPD at baseline us-
ing logistic regression, reporting odds ratios (ORs) and
95% CIs. Since the spirometry measurements were not
done post bronchodilation, and we therefore did not know
whether the airflow obstruction was reversible or not, we
also conducted a sensitivity analysis excluding individuals
with asthma at baseline from the analysis of prevalent and
incident COPD. All analyses were conducted in Stata ver-
sion 14 (Statacorp, Texas).
Results
The distribution of background characteristics according
to maternal smoking in the imputed dataset is shown in
Table 1. Participants who reported that their mother
smoked around the time of their delivery were more likely
to be male, to be of European ethnicity, to have lower edu-
cational qualifications, to have lower income, to have
smoked themselves, to have a higher BMI and to have a
history of asthma at enrolment.
The combined exposure to maternal and own smoking
was associated with a reduction in both FEV1 and FVC
that exceeded their independent associations (Table 2).
The excess reduction in standardized FEV1 was 0.0005, –
0.04, –0.08 and –0.09 for <10, 11–20, 21–30 and more
than 30 pack-years of own smoking, respectively (Table 2).
Exposure to maternal smoking showed some evidence of a
positive association with both FEV1 and FVC among never
smokers, but the mean difference was arguably very mod-
est (Table 3). In contrast, maternal smoking was associated
with lower FEV1 among individuals who had smoked
more than 20 pack-years, with a mean difference of –0.07
(95% CI: –0.12, –0.03) among those who had smoked
more than 30 pack-years (Table 3). The results were simi-
lar in the complete-case analysis (Supplementary Tables 1
and 2, available as Supplementary data at IJE online).
There was heterogeneity in the associations of maternal
and own smoking with FEV1/FVC between the sexes
(p-value< 0.001) and stratified results are therefore pre-
sented. In line with the findings for FEV1 and FVC, the
reduction in FEV1/FVC among those exposed to both ma-
ternal and own smoking also exceeded what was expected
based on the independent associations. For example,
among women, the excess reduction in FEV1/FVC due to
maternal smoking was –0.02, –0.01, –0.11 and –0.11
among those who had smoked up to 10, 11–20, 21–30 and
more than 30 pack-years, respectively (Table 4). There was
evidence of an inverse association with maternal smoking
in the two highest categories of own smoking in both sexes,
where the mean difference in FEV1/FVC was –0.11 (95%
CI: –0.19, –0.04) among women who had smoked more
than 30 years (Table 5). The results from the complete-case
analysis showed a similar trend (Supplementary Tables 3
and 4, available as Supplementary data at IJE online). An
excess reduction in FEV1/FVC due to the combined expo-
sure of maternal and pack-years of own smoking was ob-
served for both former and current smokers
(Supplementary Table 5, available as Supplementary data
at IJE online).
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433 863 participants free of COPD at baseline were in-
cluded in the analysis of incident hospitalization/death
from COPD. We found no strong evidence of an associa-
tion between maternal smoking and hospitalization/death
from COPD among never smokers (Table 6). The com-
bined exposure to maternal and own smoking was associ-
ated with a risk of hospitalization/death from COPD that
exceed those exposed to only one or the other (Table 6).
This excess risk due to maternal smoking was u-shaped,
with values of 1.72, 0.30, 1.05 and 1.27 among those who
smoked up to 10, 11–20, 21–30 and more than 30 pack-
years, respectively (Table 6). In line with the interaction,
the association with maternal smoking varied across cate-
gories of own smoking, with HRs of 2.25, 1.23, 1.30 and
1.14 among those who had smoked up to 10, 11–20, 21–
30 and more than 30 pack-years, respectively (Table 7).
Table 1. Distribution of background characteristics by maternal smoking around the time of delivery (n¼ 502626)
Background characteristic No (N¼354 529) Yes (n¼148 097) p-value
Age (median, IQR) 58 (50, 64) 57 (50, 62) <0.001
Sex (%) <0.001
Female 195 005 (55.0) 78 451 (53.0)
Male 159 524 (45.0) 69 646 (47.0)
Ethnicity (%) <0.001
European 329 126 (92.8) 146 084 (98.6)
Other 25 403 (7.2) 2013 (1.4)
Qualifications (%) <0.001
College, university or other professional 142 429 (40.2) 47 663 (32.2)
A-levels/AS-levels or equivalent 40 457 (11.4) 15 778 (10.7)
O-levels/GCSEs or equivalent 74 621 (21.0) 32 618 (22.0)
CSEs or equivalent 17 434 (4.9) 10 024 (6.8)
NVQ, HND, HNC or equivalent 21 858 (6.2) 11 626 (7.9)
Other 57 729 (16.3) 30 387 (20.5)
Average household yearly income, pounds (%) <0.001
Less than 18 000 68 508 (19.3) 30 418 (20.5)
18 000–30 999 77 043 (21.7) 32 435 (21.9)
31 000–51 999 77 646 (21.9) 34 280 (23.1)
52 000–100 000 61 600 (17.4) 25 453 (17.2)
>100 000 16 770 (4.7) 6337 (4.3)
Prefer not to answer/don’t know 52 962 (14.9) 19 175 (12.9)
Townsend area-level deprivation index (mean, SD) –2.21 (–3.68, 0.42) –1.96 (–3.53, 0.87) <0.001
Pack-years of own smoking (%) <0.001
None 234 529 (66.2) 88 517 (59.8)
Up to 10 33 098 (9.3) 12 600 (8.5)
Between 11 and 20 33 402 (9.4) 15 086 (10.2)
Between 21 and 30 23 024 (6.5) 12 484 (8.4)
More than 30 30 477 (8.6) 19 411 (13.1)
Asthma at baseline (%) <0.001
No 313 160 (88.3) 128 587 (86.8)
Yes 41 369 (11.7) 19 510 (13.2)
BMI, kg/m2 (median, IQR) 26.5 (24.0, 29.6) 27.2 (24.5, 30.6) <0.001
Height, cm (median, IQR) 168 (162, 175) 168 (161, 175) <0.001
FEV1 (median, IQR) 0.003 (–0.629, 0.623) 0.007 (–0.603, 0.621) <0.001
FVC (median, IQR) 0.037 (–0.601, 0.642) 0.025 (–0.602, 0.624) <0.001
FEV1/ FVC (median, IQR) 0.141 (–0.484, 0.671) 0.092 (–0.556, 0.631) <0.001
COPD at baseline (%) <0.001
No 307 187 (86.6) 126 677 (85.5)
Yes 47 342 (13.4) 21 421 (14.5)
COPD hospitalization/death (%) <0.001
No 306 111 (99.6) 125 974 (99.4)
Yes 1, 076 (0.4) 703 (0.6)
Number of years of follow-up from the registries (median, IQR) 6.1 (5.4, 6.7) 6.1 (5.5, 6.7) <0.001
The distribution of the covariates constitutes an average across the 20 imputed datasets.
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The findings were similar in the complete-case analysis
(Supplementary Tables 6 and 7, available as
Supplementary data at IJE online). We also evaluated po-
tential differences according to whether the participant
was a former or current smoker (Supplementary Table 8,
available as Supplementary data at IJE online). Among
current smokers, the direction of the RERI was positive for
the three lowest categories of pack-years of own smoking
and negative for the highest category of own smoking.
However, the CIs for the RERI all included the null value,
likely reflecting the small number of exposed cases.
The combined exposure to maternal and own smoking
was also associated with a risk of prevalent COPD at base-
line that exceeds their individual associations
(Supplementary Table 9, available as Supplementary data
at IJE online). The excess risk due to maternal smoking
was 0.04, 0.14, 0.13 and 0.33 among women who had
smoked up to 10, 11–20, 21–30 and more than 30 pack-
years, respectively (Supplementary Table 9, available as
Supplementary data at IJE online). There was weak evi-
dence for a positive association between maternal smoking
and COPD at baseline in the two highest categories of own
smoking (Supplementary Table 10, available as
Supplementary data at IJE online). The results from the
sensitivity analysis excluding individuals with asthma at
baseline from the analysis of prevalent and incident COPD
yielded similar results.Ta
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Table 3. Multiple-imputation analysis of maternal smoking in
relation to FVC and FEV1 at baseline according to own smok-
ing (n¼502 626)
Spirometry
measurements
Pack-years of
own smoking
Mean difference
(95% CI)a
FVC No 0.02 (0.005, 0.03)
Up to 10 0.02 (–0.009, 0.05)
Between 11 and 20 –0.006 (–0.03, 0.02)
Between 21 and 30 –0.03 (–0.07, 0.005)
More than 30 –0.03 (–0.08, 0.01)
FEV1 No 0.01 (0.004, 0.025)
Up to 10 0.01 (–0.02, 0.05)
Between 11 and 20 –0.03 (–0.05, 0.002)
Between 21 and 30 –0.07 (–0.10, –0.03)
More than 30 –0.07 (–0.12, –0.03)
The spirometry measurements are standardized by age, sex and height with
a mean of 0 and a standard deviation of 1.
aEstimates of associations with maternal smoking within groups of pack-
years of own smoking are obtained from a marginal structural model. The
probability of maternal smoking is predicted based on participant’s age, sex,
qualifications, income, Townsend area-level deprivation index and ethnicity.
The probability of own smoking is predicted based on maternal smoking, in
addition to the participant’s age, sex, qualifications, income, Townsend area-
level deprivation index, ethnicity, asthma at baseline, height and BMI.
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Discussion
In this large-scale study, exposure to both maternal and
own smoking was associated with an increased risk of
COPD and reduction in lung function that exceeded what
was expected based on their independent associations.
Whereas the interaction between maternal and own smok-
ing showed some evidence of a dose response for lung func-
tion and COPD at baseline, it was only observed in the
lowest category of own smoking for incident hospitaliza-
tion/death from COPD. The association with maternal
smoking therefore varied across categories of pack-years of
own smoking. There was no strong evidence that maternal
smoking was associated with lung function or hospitaliza-
tion/death from COPD among never smokers.
A limited number of previous studies examined mater-
nal smoking in relation to adult lung function or
COPD.4,7–9 A previous UK study of 2195 individuals be-
tween 30 and 59 years of age reported that maternal smok-
ing before birth was associated with reduced lung volume
irrespective of own smoking and appeared to interact with
own smoking to increase airflow limitation and COPD
risk.7 Another study of 18 922 subjects aged 20–44 years
Table 4. Multiple-imputation analysis of maternal and pack-years of own smoking in relation to FEV1/FVC at baseline stratified
by sex
Sex Maternal
smoking
Pack-years of
own smoking
Median (IQR) Mean difference
(95% CI)a
Additive interaction
Relative excess change (95% CI)
Women (n¼273 456) No No 0.19 (–0.41, 0.71) Ref
Up to 10 0.13 (–0.46, 0.66) –0.05 (–0.07, –0.03)
Between 11 and 20 0.04 (–0.59, 0.58) –0.17 (–0.19, –0.15)
Between 21 and 30 –0.06 (–0.73, 0.50) –0.28 (–0.31, –0.26)
More than 30 –0.28 (–1.04, 0.33) –0.53 (–0.57, –0.51)
Yes No 0.18 (–0.41, 0.69) 0.0002 (–0.01, 0.01)
Up to 10 0.11 (–0.48, 0.63) –0.07 (–0.10, –0.03) –0.02 (–0.06, 0.02)
Between 11 and 20 0.02 (–0.62, 0.56) –0.18 (–0.21, –0.15) –0.01 (–0.05, 0.03)
Between 21 and 30 –0.17 (–0.86, 0.42) –0.39 (–0.44, –0.34) –0.11 (–0.16, –0.05)
More than 30 –0.39 (–1.18, 0.26) –0.65 (–0.72, –0.58) –0.11 (–0.19, –0.04)
Men (n¼229 170) No No 0.22 (–0.40, 0.73) Ref
Up to 10 0.17 (–0.44, 0.69) –0.04 (–0.06, –0.02)
Between 11 and 20 0.14 (–0.48, 0.66) –0.07 (–0.10, –0.05)
Between 21 and 30 0.05 (–0.60, 0.59) –0.17 (–0.19, –0.15)
More than 30 –0.18 (–0.91, 0.42) –0.40 (–0.42, –0.38)
Yes No 0.21 (–0.41, 0.72) –0.001 (–0.02, 0.01)
Up to 10 0.16 (–0.45, 0.68) –0.04 (–0.08, –0.004) 0.001 (–0.04, 0.04)
Between 11 and 20 0.05 (–0.59, 0.59) –0.15 (–0.19, –0.12) –0.08 (–0.12, –0.03)
Between 21 and 30 –0.04 (–0.71, 0.53) –0.24 (–0.28, –0.20) –0.07 (–0.11, –0.02)
More than 30 –0.26 (–1.01, 0.37) –0.47 (–0.51, –0.43) –0.07 (–0.11, –0.02)
The spirometry measurements are standardized by age, sex and height with a mean of 0 and a standard deviation of 1.
aEstimates obtained from a marginal structural model. The probability of maternal smoking is predicted based on participant’s age, sex, qualifications, income,
Townsend area-level deprivation index and ethnicity. The probability of own smoking is predicted based on maternal smoking, in addition to the participant’s
age, sex, qualifications, income, Townsend area-level deprivation index, ethnicity, asthma at baseline, height and BMI.
Table 5. Multiple-imputation analysis of maternal smoking in
relation to FEV1/FVC at baseline according to own smoking
stratified by sex
Sex Pack-years of
own smoking
Mean difference
(95% CI)
Women (n¼273 456) No 0.0003 (–0.01, 0.01)
Up to 10 –0.02 (–0.06, 0.02)
Between 11 and 20 –0.01 (–0.05, 0.02)
Between 21 and 30 –0.11 (–0.16, –0.05)
More than 30 –0.11 (–0.19, –0.04)
Men (n¼229 170) No –0.001 (–0.02, 0.01)
Up to 10 0.00005 (–0.04, 0.04)
Between 11 and 20 –0.08 (–0.12, –0.04)
Between 21 and 30 –0.07 (–0.11, –0.02)
More than 30 –0.07 (–0.11, –0.03)
The spirometry measurements are standardized by age, sex and height with
a mean of 0 and a standard deviation of 1.
Estimates of associations with maternal smoking within groups of pack-
years of own smoking are obtained from a marginal structural model. The
probability of maternal smoking is predicted based on participant’s age, sex,
qualifications, income, Townsend area-level deprivation index and ethnicity.
The probability of own smoking is predicted based on maternal smoking, in
addition to the participant’s age, sex, qualifications, income, Townsend area-
level deprivation index, ethnicity, asthma at baseline, height and BMI.
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participating in the European Community Respiratory
Health Survey reported that both maternal smoking during
pregnancy and environmental tobacco smoke exposure
during childhood were associated with more respiratory
symptoms and poorer lung function in adulthood.8 Results
from the same cohort also indicated an interaction between
maternal and own smoking on the rate of lung-function
decline.9 The previous studies that attempted to examine
an interaction between maternal and own smoking used a
rather crude categorization of own smoking (never, former and
current). In the current study, we used information on pack-
years of own smoking and were able to show the complex
nuances in this interaction.
There are several potential non-exclusive explanatory
mechanisms for an influence of maternal smoking on adult
lung health. Since maternal smoking during pregnancy is
associated with low birth weight and preterm delivery,18,19
which are linked to reduced lung function in adulthood,20–22
this underlying disadvantage in the lung development of off-
spring born to mothers who smoke during pregnancy might
render them more vulnerable to COPD in adulthood.
Changes in DNA methylation and telomere length shortening
are other potential explanations for a direct effect of maternal
smoking during pregnancy on lung function and hospitaliza-
tion/death from COPD.23,24
Individuals exposed to maternal smoking might also be
more susceptible to adverse effects of their own smoking
on lung health. This interaction between maternal and
own smoking in relation to hospitalization/death from
COPD may be driven by an association between COPD
risk genes and childhood lung response to maternal smok-
ing.25 Furthermore, maternal smoking during pregnancy is
associated with lower lung function during childhood,
which subsequently tracks through adulthood,5 and COPD
is associated with lower lung function at age 40 years.26 It
is therefore plausible that the combination of a lower max-
imally attained lung function due to maternal smoking, to-
gether with a more rapid decline in lung function due to
own smoking, results in a particularly elevated risk of
COPD. These mechanisms would explain why we found
the greatest excess reduction in FEV1/FVC and excess risk
of prevalent COPD at baseline associated with maternal
smoking in the highest category of own smoking. An ex-
planation for our observation that the magnitude of the ex-
cess risk due to maternal smoking in relation to
hospitalization/death from COPD was highest in the two
extreme categories of own smoking could be that individu-
als exposed to both maternal and own smoking experience
an earlier disease onset. If this is the case, the study
Table 6. Multiple-imputation analysis of maternal and pack-years of own smoking in relation to incident hospitalization/death
from chronic obstructive pulmonary disease (n¼ 433863)
Maternal
smoking
Pack-years of
own smoking
N n (%) cases HR (95% CI)a Additive interaction
Relative excess change (95% CI)
No No 209, 546 247 (0.1) 1
Up to 10 29, 226 55 (0.2) 1.61 (1.15, 2.26)
Between 11 and 20 28, 384 115 (0.4) 2.70 (2.04, 3.57)
Between 21 and 30 18, 658 146 (0.8) 4.49 (3.46, 5.82)
More than 30 21, 373 514 (2.4) 11.33 (9.20, 13.97)
Yes No 79, 445 120 (0.2) 1.32 (0.98, 1.77)
Up to 10 11, 141 46 (0.4) 3.62 (2.32, 5.66) 1.72 (0.10, 3.34)
Between 11 and 20 12, 789 68 (0.5) 3.32 (2.32, 4.76) 0.30 (–1.14, 1.75)
Between 21 and 30 10, 040 94 (0.9) 5.85 (3.92, 8.74) 1.05 (–1.34, 3.44)
More than 30 13, 261 375 (2.8) 12.94 (10.34, 16.19) 1.27 (–1.57, 4.12)
aEstimates obtained from a marginal structural model. The inverse probability of maternal smoking is predicted based on participant’s age, sex, qualifications,
income, Townsend area-level deprivation index and ethnicity. The inverse probability of own smoking is predicted based on maternal smoking, in addition to the
participant’s age, sex, qualifications, income, Townsend area-level deprivation index, ethnicity, asthma at baseline, height and BMI.
Table 7. Multiple-imputation analysis of maternal smoking in
relation to incident hospitalization/death from chronic obstruc-
tive pulmonary disease according to own smoking (n¼ 433863)
Pack-years of own smoking HR (95% CI)
No 1.32 (0.98, 1.77)
Up to 10 2.25 (1.30, 3.89)
Between 11 and 20 1.23 (0.80, 1.89)
Between 21 and 30 1.30 (0.85, 2.01)
More than 30 1.14 (0.91, 1.43)
Estimates of associations with maternal smoking within groups of pack-
years of own smoking are obtained from a marginal structural model.
The probability of maternal smoking is predicted based on participant’s age,
sex, qualifications, income, Townsend area-level deprivation index and ethnic-
ity. The probability of own smoking is predicted based on maternal smoking,
in addition to the participant’s age, sex, qualifications, income, Townsend area-
level deprivation index, ethnicity, asthma at baseline, height and BMI.
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population included in the evaluation of incident hospitali-
zation/death from COPD might constitute healthier/more
resilient people. However, further evidence is necessary to
clarify whether this might be the case.
The main strengths of the current study is the size,
which provided adequate power to test for an interaction
between maternal smoking and different categories of
pack-years of own smoking, the prospective follow-up and
linkage to national registers. Our study also has limita-
tions. The low participation rate in UK Biobank suggests
potential for selection bias. The proportion of current
smokers in UK Biobank was lower than estimates from the
UK Office of National Statistics (11 vs 20%).27 This selec-
tion will influence the generalizability of our findings, but
does not necessarily influence the internal validity.28–30
Due to the fact that the spirometry measurements were not
conducted post bronchodilation, we might have over-
estimated the number of individuals we classified with
COPD at baseline. Our choice of using a fixed ratio of
FEV1/FVC <0.70 as a proxy for prevalent COPD has limi-
tations. Using this criterion might have contributed to an
over-estimation of COPD due to the age of the UK
Biobank participants. The alternative would have been to
use cut-off levels based on the lower limit of normal for
FEV1/FVC. However, this alternative approach has its own
limitations, as it is dependent on the reference equations
that you use, and it has not been validated in longitudinal
studies.12 We also acknowledge that incident hospitaliza-
tion/death from COPD, as captured from the hospital and
death registers, reflects more severe COPD cases. Using the
information available to us, we were not able to capture in-
cident cases of COPD that occurred after baseline that did
not require hospitalization and were not registered on the
death certificate.
Asking adults to recall maternal smoking may also have
resulted in misclassification. Whereas adults might recall
maternal smoking during their childhood years, they can-
not remember maternal smoking around the time of their
delivery. We might therefore speculate that adult offspring
are more likely to report that their mother smoked around
the time of their delivery if she continued smoking during
their childhood years. However, a validation study from
the US Nurses Health Study indicated a reasonable validity
of offspring’s report that their mother smoked around the
time of their delivery compared with asking the mothers di-
rectly.31 Despite these findings, we cannot exclude an in-
fluence of differential misclassification of maternal and/or
own smoking. For example, heavy smokers might be more
likely both to under-report their own smoking and to recall
that their mothers smoked. Such a differential misclassifi-
cation might have lead us to underestimate the associations
with own smoking and overestimate the association with
maternal smoking. It is also possible that participants
changed their smoking status after the baseline follow-up.
A repeat assessment was conducted for 20 000 UK
Biobank participants a median of 4 years after the main
data collection. Of the participants who reported that they
were current smokers at baseline, 36% reported that they
had quit at the follow-up visit. For individuals who contin-
ued smoking after baseline, we likely underestimated their
amount of exposure to own smoking, depending on
how much they smoked after baseline and the timing of
hospitalization/death from COPD. Lastly, since we did not
have any direct measures of maternal socio-economic posi-
tion, we cannot exclude unmeasured confounding.
In conclusion, our findings indicate an excess reduction
of FEV1/FVC and risk of COPD due to maternal smoking
that is heterogeneous across levels of own smoking. This
further emphasizes the importance of smoking avoidance
and cessation for lung health, and suggests that public-
health initiatives supporting the current trend of reduction
in smoking may have benefits for two generations.
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Funding
This work was supported by the UK Medical Research Council
(grant number MC_UU_12013/5, MR/M009351/1 to A.F. and MR/
M020894/1 to L.D.H.). This study was also supported by the
National Institute for Health Research Biomedical Research Centre
at the University Hospitals Bristol National Health Service
Foundation Trust and the University of Bristol. This work was also
partly supported by the Research Council of Norway through its
Centres of Excellence funding scheme, project number 262700. The
views expressed in this publication are those of the author(s) and
not necessarily the funders.
Acknowledgements
This research has been conducted using the UK Biobank Resource
(application number 6326).
Conflict of interest: None declared.
References
1. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in
non-smokers. Lancet 2009;374:733–43.
2. Boucherat O, Morissette MC, Provencher S, Bonnet S, Maltais
F. Bridging lung development with chronic obstructive pulmo-
nary disease. relevance of developmental pathways in chronic
obstructive pulmonary disease pathogenesis. Am J Respir Crit
Care Med 2016;193:362–75.
3. Martinez FD. Early-life origins of chronic obstructive pulmonary
disease.NEngl J Med 2016;375:871–78.
International Journal of Epidemiology, 2018, Vol. 0, No. 0 9
D
ow
nloaded from
 https://academ
ic.oup.com
/ije/advance-article-abstract/doi/10.1093/ije/dyy221/5137112 by guest on 14 N
ovem
ber 2018
4. Svanes C, Sunyer J, Plana E et al. Early life origins of chronic ob-
structive pulmonary disease. Thorax 2010;65:14–20.
5. Stern DA, Morgan WJ, Wright AL, Guerra S, Martinez FD. Poor
airway function in early infancy and lung function by age 22 years:
a non-selective longitudinal cohort study. Lancet 2007;370:758–64.
6. Gibbs K, Collaco JM, McGrath-Morrow SA. Impact of tobacco
smoke and nicotine exposure on lung development. Chest 2016;
149:552–61.
7. Upton MN, Smith GD, McConnachie A, Hart CL, Watt GC.
Maternal and personal cigarette smoking synergize to increase
airflow limitation in adults. Am J Respir Crit Care Med 2004;
169:479–87.
8. Svanes C, Omenaas E, Jarvis D, Chinn S, Gulsvik A, Burney P.
Parental smoking in childhood and adult obstructive lung dis-
ease: results from the European Community Respiratory Health
Survey. Thorax 2004;59:295–302.
9. Dratva J, Zemp E, Dharmage SC et al. Early life origins of lung
ageing: early life exposures and lung function decline in adult-
hood in two European cohorts aged 28–73 years. PLoS One
2016;11:e0145127.
10. Allen NE, Sudlow C, Peakman T, Collins R. UK Biobank data:
come and get it. Sci Transl Med 2014;6:224ed4.
11. Sudlow C, Gallacher J, Allen N et al. UK Biobank: an open access
resource for identifying the causes of a wide range of complex dis-
eases of middle and old age. PLoSMed 2015;12:e1001779.
12. Vogelmeier CF, Criner GJ, Martinez FJ et al. Global strategy for
the diagnosis, management, and prevention of chronic obstruc-
tive lung disease 2017 report: GOLD executive summary. Am J
Respir Crit Care Med 2017;195:557–82.
13. Lee KJ, Carlin JB. Multiple imputation for missing data: fully
conditional specification versus multivariate normal imputation.
Am J Epidemiol 2010;171:624–32.
14. Cole SR, Hernan MA. Constructing inverse probability weights for
marginal structural models.Am J Epidemiol 2008;168:656–64.
15. Robins JM, Hernan MA, Brumback B. Marginal structural mod-
els and causal inference in epidemiology. Epidemiology 2000;
11:550–60.
16. VanderWeele TJ. Marginal structural models for the estimation
of direct and indirect effects. Epidemiology 2009;20:18–26.
17. VanderWeele TJ. Sufficient cause interactions and statistical
interactions. Epidemiology 2009;20:6–13.
18. Davies DP, Abernethy M. Cigarette smoking in pregnancy: asso-
ciations with maternal weight gain and fetal growth. Lancet
1976;1:385–87.
19. Brooke OG, Anderson HR, Bland JM, Peacock JL, Stewart CM.
Effects on birth weight of smoking, alcohol, caffeine, socioeco-
nomic factors, and psychosocial stress. BMJ 1989;298:795–801.
20. Baumann S, Godtfredsen NS, Lange P, Pisinger C. The impact of
birth weight on the level of lung function and lung function de-
cline in the general adult population: the Inter99 study. Respir
Med 2015;109:1293–99.
21. Suresh S, Mamun AA, O’Callaghan M, Sly PD. The impact of
birth weight on peak lung function in young adults. Chest 2012;
142:1603–10.
22. Cai Y, Shaheen SO, Hardy R, Kuh D, Hansell AL. Birth weight,
early childhood growth and lung function in middle to early old
age: 1946 British birth cohort. Thorax 2016;71:916–22.
23. Richmond RC, Simpkin AJ, Woodward G et al. Prenatal expo-
sure to maternal smoking and offspring DNA methylation across
the lifecourse: findings from the Avon Longitudinal Study of
Parents and Children (ALSPAC). Hum Mol Genet 2015;24:
2201–17.
24. Salihu HM, Pradhan A, King L et al. Impact of intrauterine to-
bacco exposure on fetal telomere length. Am J Obstet Gynecol
2015;212:205.e1–e8.
25. Kerkhof M, Boezen HM, Granell R et al. Transient early wheeze
and lung function in early childhood associated with chronic ob-
structive pulmonary disease genes. J Allergy Clin Immunol 2014;
133:68–64.
26. Lange P, Celli B, Agusti A et al. Lung-function trajectories lead-
ing to chronic obstructive pulmonary disease. N Engl J Med
2015;373:111–22.
27. UK Office of National Statistics. Adult Smoking Habits in Great
Britain. 2013. http://www.ons.gov.uk/peoplepopulationandcom
munity/healthandsocialcare/healthandlifeexpectancies/compen
dium/opinionsandlifestylesurvey/2015–03-19/adultsmokingha
bitsingreatbritain2013 (19 July 2017, date last accessed].
28. Ebrahim S, Davey Smith G. Commentary: should we always de-
liberately be non-representative? Int J Epidemiol 2013;42:
1022–26.
29. Richiardi L, Pizzi C, Pearce N. Commentary: representativeness
is usually not necessary and often should be avoided. Int J
Epidemiol 2013;42:1018–22.
30. Rothman KJ, Gallacher JE, Hatch EE. Why representativeness
should be avoided. Int J Epidemiol 2013;42:1012–14.
31. Simard JF, Rosner BA, Michels KB. Exposure to cigarette smoke
in utero: comparison of reports from mother and daughter.
Epidemiology 2008;19:628–33.
10 International Journal of Epidemiology, 2018, Vol. 0, No. 0
D
ow
nloaded from
 https://academ
ic.oup.com
/ije/advance-article-abstract/doi/10.1093/ije/dyy221/5137112 by guest on 14 N
ovem
ber 2018
